| Thomas Cherneskie, MD | |
|
160 W 100th St, Room 136, New York, NY 10025-5145 | |
| (646) 364-0958 | |
| (646) 364-0798 |
| Full Name | Thomas Cherneskie |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 160 W 100th St, New York, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316189988 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 203938 (New York) | Primary |
| Entity Name | City Of New York Office Of Payroll Administration |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942257035 PECOS PAC ID: 9739172644 Enrollment ID: O20040406001483 |
News Archive
Non-physical abuse by a dating partner such as threats, controlling behavior and harassing text messages can have a serious effect on a teenager's health and well-being, finds new research led by a Michigan State University scholar.
The first Phase II study to investigate the use of the anti-cancer drug, everolimus, for the initial treatment of advanced papillary kidney cancer has shown that it is successful in slowing or preventing the spread of the disease, according to research to be presented today (Sunday) at the 2013 European Cancer Congress.
Ligand Pharmaceuticals Incorporated today reported financial results for the first quarter ended March 31, 2012, and provided an operating forecast and program updates.
The Z-Deck range from Prior Scientific set the benchmark for top quality, height adjustable platforms designed specifically for upright microscopes used in electrophysiology and neuroscience applications, including Nikon FN1, Olympus BX51WI or BX61WI, Zeiss Axio Examiner and Leica DM6 microscopes.
ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today that results from preclinical studies of darinaparsin (Zinapar or ZIO-101), a novel organic arsenic, in prostate cancer were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place November 12-16 in San Francisco.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Cherneskie, MD 160 W 100th St, Room 136, New York, NY 10025-5145 Ph: (646) 364-0958 | Thomas Cherneskie, MD 160 W 100th St, Room 136, New York, NY 10025-5145 Ph: (646) 364-0958 |
News Archive
Non-physical abuse by a dating partner such as threats, controlling behavior and harassing text messages can have a serious effect on a teenager's health and well-being, finds new research led by a Michigan State University scholar.
The first Phase II study to investigate the use of the anti-cancer drug, everolimus, for the initial treatment of advanced papillary kidney cancer has shown that it is successful in slowing or preventing the spread of the disease, according to research to be presented today (Sunday) at the 2013 European Cancer Congress.
Ligand Pharmaceuticals Incorporated today reported financial results for the first quarter ended March 31, 2012, and provided an operating forecast and program updates.
The Z-Deck range from Prior Scientific set the benchmark for top quality, height adjustable platforms designed specifically for upright microscopes used in electrophysiology and neuroscience applications, including Nikon FN1, Olympus BX51WI or BX61WI, Zeiss Axio Examiner and Leica DM6 microscopes.
ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today that results from preclinical studies of darinaparsin (Zinapar or ZIO-101), a novel organic arsenic, in prostate cancer were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place November 12-16 in San Francisco.
› Verified 2 days ago
Gerard P Varlotta, D.O Preventive Medicine Medicare: May Accept Medicare Assignments Practice Location: 20 E 46th St Rm 304, New York, NY 10017 Phone: 212-725-1800 | |
Dr. Thomas Gregory Mckelvey Jr., M.D., M.P.H. Preventive Medicine Medicare: Medicare Enrolled Practice Location: 1 World Trade Ctr Fl 80, New York, NY 10007 Phone: 646-584-7213 | |
Dr. Allen Robert Feldman, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 W End Ave, 8b, New York, NY 10024 Phone: 212-769-4629 Fax: 212-769-4629 | |
Dr. John C Rausch, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: 3959 Broadway, Columbia Unversity Department Pediatric, New York, NY 10032 Phone: 212-304-7250 Fax: 212-544-1974 | |
Dr. Eugenio Cruz Mateo, MD,MPH&TM Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 125 White St, New York, NY 10013 Phone: 212-225-1482 Fax: 212-225-1489 | |
Dr. Robert Raymond Boesch, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 290 Broadway, Suite 215, New York, NY 10007 Phone: 212-637-3003 Fax: 212-637-5155 | |
Dr. Kelly Andre Jarrett, M.D. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 2006 Madison Ave, New York, NY 10035 Phone: 212-633-0815 |